Anti-IL-12/23 [ABT-874 (Briakinumab)]
Ab00722-2.0
ApplicationsNeutralisation/Blocking
Product group Antibodies
TargetIL12B
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IL-12/23 [ABT-874 (Briakinumab)]
- Delivery Days Customer7
- Application Supplier NoteThis antibody binds to and neutralises human IL12 and IL23.
- ApplicationsNeutralisation/Blocking
- Applications Supplierblock
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDABT-874 (Briakinumab)
- Gene ID3593
- Target nameIL12B
- Target descriptioninterleukin 12B
- Target synonymsCLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF, NKSF2, interleukin-12 subunit beta, CLMF p40, IL-12 subunit p40, IL12, subunit p40, NK cell stimulatory factor chain 2, cytotoxic lymphocyte maturation factor 40 kDa subunit, interleukin 12, p40, interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), interleukin-12 beta chain, natural killer cell stimulatory factor, 40 kD subunit
- HostMouse
- IsotypeIgG2a
- Protein IDP29460
- Protein NameInterleukin-12 subunit beta
- Scientific DescriptionThis chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Reactivity SupplierHuman
- Reactivity Supplier NoteThis antibody was generated by phage display technology.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203




